Metabolic conditioning and metabolic actuation: experimental approaches to cancer chemotherapy involving combinations of metabolites and antimetabolites.
D000818:Animals; D000963:Antimetabolites / Q000378:metabolism / Q000494:pharmacology / Q000627:therapeutic use*; D000970:Antineoplastic Agents / Q000494:pharmacology; D001419:Bacteria / Q000201:enzymology; D001702:Biopharmaceutics; D002250:Carbon Radioisotopes; D002286:Carcinoma, Ehrlich Tumor / Q000378:metabolism; D004848:Epithelium / Q000187:drug effects; D005260:Female; D006147:Guanine / Q000494:pharmacology; D006151:Guanosine / Q000494:pharmacology; D008297:Male; D015122:Mercaptopurine / Q000494:pharmacology; D051379:Mice; D008811:Mice, Inbred DBA; D009369:Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D011041:Poisoning / Q000188:drug therapy; D011687:Purines / Q000037:antagonists & inhibitors; D011743:Pyrimidines / Q000138:chemical synthesis; D013291:Streptococcus / Q000187:drug effects; D013739:Testosterone / Q000494:pharmacology / Q000627:therapeutic use
D000963:Antimetabolites; D000970:Antineoplastic Agents; D002250:Carbon Radioisotopes; D011687:Purines; D011743:Pyrimidines; D006151:Guanosine; D013739:Testosterone; D006147:Guanine; D015122:Mercaptopurine